Hester Biosciences Ltd
Hester Biosciences Ltd Share Price Today: Live Updates & Key Insights
Get insights on Hester Biosciences Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Hester Biosciences Ltd Share Price Chart
Hester Biosciences Ltd Fundamentals
Traded Volume: 9,016
Market Cap(Cr): 1,453
Avg Traded Price 1530.96
1 Year return -33.48%
Upper Circuit 1,734.5
Lower Circuit 1,680
P/E TTM 33.00
P/B Ratio 52.00
Traded Value(Cr) 153.98
EPS TTM 51.539
Book value 51.539
Dividend 0.00%
Hester Biosciences Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Hester Biosciences Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Hester Biosciences Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W +7.32%
1M +0.70%
3M -12.23%
1Y -33.48%
YTD -29.59%
Hester Biosciences Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Hester Biosciences Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 78291.00
Day Before Yesterday 8058.00
1W Avg 21030.20
1M Avg 10013.19
3M Avg 7723.61
Hester Biosciences Ltd Technical Details
Hester Biosciences Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 1578
Support 2 1473
Support 3 1372
Pivot Point : 1679
Resistance 1 1784
Resistance 2 1885
Resistance 3 1991
Hester Biosciences Ltd Corporate Actions
Hester Biosciences Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Hester Biosciences Ltd’s capital allocation strategies.
All
Ex-Date 06-Aug-2025 Type D Description 7.00/share@70.00% Record Date 06-Aug-2025 Ratio 70.00
Ex-Date 22-Aug-2024 Type D Description 6.00/share@60.00% Record Date 13-Nov-2025 Ratio 60.00
Ex-Date 13-Sep-2023 Type D Description 8.00/share@80.00% Record Date 13-Nov-2025 Ratio 80.00
Ex-Date 11-Aug-2022 Type D Description 10.00/share@100.00% Record Date 12-Aug-2022 Ratio 100.00
Ex-Date 05-Aug-2021 Type D Description 10.00/share@100.00% Record Date 13-Nov-2025 Ratio 100.00
Ex-Date 27-Aug-2020 Type D Description 6.60/share@66.00% Record Date 13-Nov-2025 Ratio 66.00
Ex-Date 18-Jul-2019 Type D Description 7.00/share@70.00% Record Date 13-Nov-2025 Ratio 70.00
Ex-Date 09-Nov-2018 Type D Description 2.00/share@20.00% Record Date 12-Nov-2018 Ratio 20.00
Ex-Date 30-Aug-2018 Type D Description 2.00/share@20.00% Record Date 31-Aug-2018 Ratio 20.00
Ex-Date 02-Aug-2018 Type D Description 6.00/share@60.00% Record Date 13-Nov-2025 Ratio 60.00
Ex-Date 16-Nov-2017 Type D Description 4.00/share@40.00% Record Date 17-Nov-2017 Ratio 40.00
Ex-Date 20-Jul-2017 Type D Description 2.30/share@23.00% Record Date 13-Nov-2025 Ratio 23.00
Ex-Date 03-Nov-2016 Type D Description 3.00/share@30.00% Record Date 04-Nov-2016 Ratio 30.00
Ex-Date 21-Jul-2016 Type D Description 1.10/share@11.00% Record Date 13-Nov-2025 Ratio 11.00
Ex-Date 17-Mar-2016 Type D Description 3.00/share@30.00% Record Date 18-Mar-2016 Ratio 30.00
Ex-Date 10-Sep-2015 Type D Description 3.10/share@31.00% Record Date 13-Nov-2025 Ratio 31.00
Ex-Date 18-Sep-2014 Type D Description 2.00/share@20.00% Record Date 13-Nov-2025 Ratio 20.00
Ex-Date 07-Aug-2013 Type D Description 2.00/share@20.00% Record Date 13-Nov-2025 Ratio 20.00
Ex-Date 27-Sep-2012 Type B Description share@1:2 Record Date 13-Nov-2025 Ratio 1:2
Ex-Date 27-Aug-2012 Type D Description 1.00/share@10.00% Record Date 28-Aug-2012 Ratio 10.00
Ex-Date 25-Aug-2011 Type D Description 3.50/share@35.00% Record Date 13-Nov-2025 Ratio 35.00
Ex-Date 22-Jul-2010 Type D Description 3.00/share@30.00% Record Date 13-Nov-2025 Ratio 30.00
Ex-Date 13-Aug-2009 Type D Description 2.50/share@25.00% Record Date 13-Nov-2025 Ratio 25.00
Ex-Date 21-Aug-2008 Type D Description 2.50/share@25.00% Record Date 13-Nov-2025 Ratio 25.00
Ex-Date 06-Sep-2007 Type D Description 2.00/share@20.00% Record Date 13-Nov-2025 Ratio 20.00
Dividends
Announcement Date 06-Aug-2025 Ex Dividend Date 06-Aug-2025 Dividend(%) 70
Announcement Date 22-Aug-2024 Ex Dividend Date 22-Aug-2024 Dividend(%) 60
Announcement Date 13-Sep-2023 Ex Dividend Date 13-Sep-2023 Dividend(%) 80
Announcement Date 11-Aug-2022 Ex Dividend Date 11-Aug-2022 Dividend(%) 100
Announcement Date 05-Aug-2021 Ex Dividend Date 05-Aug-2021 Dividend(%) 100
Announcement Date 27-Aug-2020 Ex Dividend Date 27-Aug-2020 Dividend(%) 66
Announcement Date 18-Jul-2019 Ex Dividend Date 18-Jul-2019 Dividend(%) 70
Announcement Date 09-Nov-2018 Ex Dividend Date 09-Nov-2018 Dividend(%) 20
Announcement Date 30-Aug-2018 Ex Dividend Date 30-Aug-2018 Dividend(%) 20
Announcement Date 02-Aug-2018 Ex Dividend Date 02-Aug-2018 Dividend(%) 60
Announcement Date 16-Nov-2017 Ex Dividend Date 16-Nov-2017 Dividend(%) 40
Announcement Date 20-Jul-2017 Ex Dividend Date 20-Jul-2017 Dividend(%) 23
Announcement Date 03-Nov-2016 Ex Dividend Date 03-Nov-2016 Dividend(%) 30
Announcement Date 21-Jul-2016 Ex Dividend Date 21-Jul-2016 Dividend(%) 11
Announcement Date 17-Mar-2016 Ex Dividend Date 17-Mar-2016 Dividend(%) 30
Announcement Date 10-Sep-2015 Ex Dividend Date 10-Sep-2015 Dividend(%) 31
Announcement Date 18-Sep-2014 Ex Dividend Date 18-Sep-2014 Dividend(%) 20
Announcement Date 07-Aug-2013 Ex Dividend Date 07-Aug-2013 Dividend(%) 20
Announcement Date 27-Aug-2012 Ex Dividend Date 27-Aug-2012 Dividend(%) 10
Announcement Date 25-Aug-2011 Ex Dividend Date 25-Aug-2011 Dividend(%) 35
Announcement Date 22-Jul-2010 Ex Dividend Date 22-Jul-2010 Dividend(%) 30
Announcement Date 13-Aug-2009 Ex Dividend Date 13-Aug-2009 Dividend(%) 25
Announcement Date 21-Aug-2008 Ex Dividend Date 21-Aug-2008 Dividend(%) 25
Announcement Date 06-Sep-2007 Ex Dividend Date 06-Sep-2007 Dividend(%) 20
Bonus
Record Date Ex-Bonus Date 27-Sep-2012 Ratio 1:2
Splits
No Split has been declared by HESTERBIO
Others
Rights No Rights has been declared by HESTERBIO
Hester Biosciences Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Hester Biosciences Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Hester Biosciences Ltd's relative performance and valuation against major competitors.
Stock Name Bliss GVS Pharma Ltd ₹167.43 (+4.21%) M. Cap (Cr) 17.70 1 Yr Return (%) +41.10% P/E (TTM) 16.15 PB Ratio 1.75
Stock Name Beta Drugs Ltd ₹1675.25 (-0.07%) M. Cap (Cr) 16.91 1 Yr Return (%) -15.06% P/E (TTM) 39.87 PB Ratio 9.35
Stock Name Syncom Formulations (India) Ltd ₹16.67 (+1.89%) M. Cap (Cr) 15.67 1 Yr Return (%) -21.37% P/E (TTM) 25.06 PB Ratio 4.62
Stock Name Hester Biosciences Ltd ₹1707.90 (+1.45%) M. Cap (Cr) 14.53 1 Yr Return (%) -33.48% P/E (TTM) 33.14 PB Ratio 4.62
Stock Name Bajaj Healthcare Ltd ₹446.70 (-0.56%) M. Cap (Cr) 14.11 1 Yr Return (%) +16.00% P/E (TTM) 30.78 PB Ratio 3.16
Stock Name Jagsonpal Pharmaceuticals Ltd ₹209.77 (-1.95%) M. Cap (Cr) 14.00 1 Yr Return (%) -6.59% P/E (TTM) 22.60 PB Ratio 7.10
Stock Name Sigachi Industries Ltd ₹35.33 (-2.70%) M. Cap (Cr) 13.50 1 Yr Return (%) -31.70% P/E (TTM) -24.53 PB Ratio 2.25
Hester Biosciences Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Hester Biosciences Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 63.97 Mar 2024 42.81 Mar 2023 33.36 Mar 2022 15.90 Mar 2021 40.07
PARTICULARS Investing Activities Mar 2025 -19.04 Mar 2024 -20.63 Mar 2023 -71.96 Mar 2022 -110.58 Mar 2021 -2.69
PARTICULARS Financing Activities Mar 2025 -46.35 Mar 2024 -24.07 Mar 2023 41.38 Mar 2022 94.96 Mar 2021 -41.32
PARTICULARS Net Cash Flow Mar 2025 -1.42 Mar 2024 -1.89 Mar 2023 2.77 Mar 2022 0.28 Mar 2021 -3.95
Hester Biosciences Ltd Shareholding Pattern
This shows the ownership breakdown of Hester Biosciences Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 53.73%
Public 45.73%
Other Institutions 0.0%
FII 0.53%
Mutual Funds null%
About Hester Biosciences Ltd
Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India. The Company was incorporated in April, 1987 and is engaged in manufacturing of Poultry vaccines and Large Animal Vaccines and trading of Poultry and Large animal and Petcare health products having its manufacturing set up at Meda Adraj Village, Mehsana District, Gujarat. The Company built a presence in several regions of Africa and in numerous nations, including Vietnam, Indonesia, Nepal, and Bangladesh. The products and services included over 51 vaccines and 70+ health products. In addition, it offers a vast selection of pharmaceuticals, feed supplements, and disinfectants for poultry and large animals.The Company markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium.The company's own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation.During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun.The company received licenses for producing 10 additional poultry vaccines. It signed a manufacturing agreement with Sinsui Inc for producing poultry vaccines.In 2003, Hester was appointed as the exclusive Indian distributor by BIOPHARM of Czech Republic, for their coccidiosis vaccine - LIVACOX.Hester commenced business with Merial in the 3rd quarter of the financial year by importing poultry vaccines from them in 2004-05 and therefore, name of Company was changed from HESTER PHARMACEUTICALS LIMITED to HESTER BIOSCIENCES LIMITED. The Company embarked on an expansion program, to increase its capacity from 1200 million doses to 4800 million doses, which was commenced in January 2006. The expansion project and the new expanded capacity went on-stream in March 2007. The distribution network within India was made functional with company managed depots at Pune, Bangalore, Coimbatore, Hyderabad and Chandigarh, having state-of-art cold store facilities to maintain the cold chain. Distribution costs were further cut by embarking on the use of company owned refrigerated vans for deliveries all across India. In January 2010, the company re-launched the freeze dried MD Vaccine after 5 years. A JV was set-up in Nepal to facilitate manufacture of specific animal vaccines for international markets in 2011 for a project which costed Rs 15 crores. New technology was acquired. The Company signed a technology transfer agreement with Indian Veterinary Research Institute for acquiring technology to manufacture PPR and Sheep Pox vaccines in 2011. Company re-launched the bivalent Marek's Disease Live vaccine for the poultry, containing HVT & SB1 strains in 2012-13. It operationalised large animal vaccines division in Mar' 15. During the financial year 2014-15, Gujarat Agrofarm Limited became a wholly owned subsidiary of the Company. During financial year 2015-16, three wholly owned subsidiary Companies namely Gujarat Agrofarm Limited, Diavetra Lifesciences Private Limited and Hester Biosciences (Mauritius) Limited got merged with Company through a Scheme of Arrangement effective on 8 December 2015. Accordingly, the Company allotted and listed its 65 Equity Shares pursuant to Scheme of Arrangement vide order passed by Hon'ble High Court of Gujarat dated 8 December 2015 and the said Shares were listed at NSE Limited and BSE Limited in March, 2016. Leruarua Vetcare (Proprietary) Limited, incorporated in Botswana became an Associate Company with 49% stake of the Company and Innoves Animal Health Private Limited ceases to be an Associate Company due to transfer of shareholding of the Company in FY 2015-16.The Nepal unit completed trial operations and began commercial manufacturing in November, 2016. Leruarua Vetcare (Proprietary) Limited, Botswana ceases to be an Associate Company due to buyback of entire shareholding by the Associate Company during the FY 2016-17. The Company held 65% stake in subsidiary Company, Hester Biosciences Nepal Private Limited (HBNPL) and consequently, HBNPL became a subsidiary of Hester Biosciences Limited (Parent Company) during FY 2016-17.During the year 2017-18, Company acquired 54.80% in the capital of Texas Laboratories, a firm having a business place at Mehsana Distt. of Gujarat. In June 2017, Texas Laboratories converted into Private Limited Company namely, Texas Lifesciences Private Limited. Further, the Company incorporated 100% wholly-owned subsidiary, Hester Biosciences Africa Limited in Tanzania. During the year 2018-19, Hester Biosciences Limited incorporated 100% wholly-owned subsidiary Hester Biosciences Kenya Limited in Kenya. The Company commissioned the vaccine manufacturing plant at Tanzania in 2021. It launched the Petcare Division in 2022.In FY 2022, Company acquired 50% stake in Tanzania based Thrishool Exim Limited, company of vaccines and animal health products in Tanzania. It launched 3 products for anti-infective, specialty nutrition, parasiticides and grooming. It commenced production of Newcastle Disease and Gumboro vaccines for poultry, and PPR and Contagious Bovine Pleuropneumonia (CBPP) vaccines for large animals.The Company launched new feed supplements and disinfectants, which started to gain traction in the market in FY25.
Chairman (Non-Executive)
Bhupendra V Gandhi
Registered office 1st Flr PushpakPachvati Circle, Motilal Hirabhai Road, Ahmedabad, Gujarat, 380006
FAX :91-079-26445107
Background
Incorporation Year 1987
Face Value ₹10.00
Market Lot 1
FAQs on Hester Biosciences Ltd
How to buy Hester Biosciences Ltd shares on NSE?
To buy Hester Biosciences Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Hester Biosciences Ltd share price today?
The Hester Biosciences Ltd share price on NSE is ₹1707.90 today.
What is the market cap of Hester Biosciences Ltd on NSE?
The company has a market capitalization of ₹1452.89.
What is the PE & PB ratio of Hester Biosciences Ltd?
PE is 33 and PB is 52.
What is the 52 Week High and Low of Hester Biosciences Ltd shares?
Hester Biosciences Ltd stock price high: ₹2768 Hester Biosciences Ltd stock price low: ₹1242.95.